| Previous Close | 84.64 |
| Open | 84.43 |
| Bid | 84.00 x 300 |
| Ask | 84.20 x 500 |
| Day's Range | 84.01 - 85.13 |
| 52 Week Range | 64.18 - 86.72 |
| Volume | 2,336,672 |
| Avg. Volume | 3,458,931 |
| Market Cap | 88.19B |
| Beta | 0.12 |
| PE Ratio (TTM) | 36.44 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.54%) |
| Ex-Dividend Date | 2017-08-11 |
| 1y Target Est | N/A |
- Zacks•4 hours ago
Axovant Sciences (AXON) Stock Crashed Over 70%: Here's Why
On Tuesday, shares of biopharmaceutical company Axovant Sciences Ltd. (AXON) have crashed, and the stock is currently down over 70% to $6.72 per share in late-morning trading after it said that its experimental Alzheimer's drug failed a key late-stage trial.
- Zacks•10 hours ago
J&J's Arthritis Candidate Sirukumab Denied FDA Approval
J&J (JNJ) said that the FDA has denied approval to its investigational rheumatoid arthritis treatment, sirukumab for want of additional safety data.
Markit•yesterdaySee what the IHS Markit Score report has to say about Eli Lilly And Co.
Eli Lilly And Co NYSE:LLY
